de Bruijn Johan A, van Zantvoort Aniek P M, Winkes Michiel B, Raaymakers Leo, van der Cruijsen-Raaijmakers Marike, Hoogeveen Adwin R, Scheltinga Marc R
Department of Surgery, Máxima Medical Center, Veldhoven, the Netherlands
Department of Surgery, Máxima Medical Center, Veldhoven, the Netherlands.
Foot Ankle Int. 2015 Dec;36(12):1475-82. doi: 10.1177/1071100715596081. Epub 2015 Jul 28.
Operative management of chronic exertional compartment syndrome of the tibialis anterior muscle compartment (ant-CECS) usually involves the use of a fasciotome. Collateral tissue damage such as hematoma and nerve damage may occur during the procedure. The current report assessed the feasibility and safety of an alternative tool for the operative management of ant-CECS.
The system had a speculum-like hollow tube that was inserted via a 2-cm skin incision and allowed for the protected advancement of a fasciotome. The device was tested in patients with bilateral ant-CECS. Symptoms were prospectively scored before and after surgery using a 5-category verbal rating scale (VRS). Fourteen patients (age 26 ± 10 years) were analyzed. Complications and operative efficacy were determined using physical examination and questionnaires after 21 (range = 16-25) months.
Technical operative success rate was 100% (28/28 legs). Operation time was 10 ± 2 minutes per leg (range = 6-14). Perioperative complications were not observed. One superficial wound infection was treated nonoperatively. Significant reductions in pain (-2.2 ± 1.1 on 5-point VRS, P < .001), tightness (-1.9 ± 1.6, P = .01), cramps (-1.4 ± 1.6, P = .009), muscle weakness (-1.6 ± 1.2, P < .001), and altered sensibility (-1.3 ± 1.4, P = .005) were registered 21 months postoperatively.
This fasciotome was simple to use and allowed for a safe fasciotomy in patients with leg ant-CECS. A randomized controlled trial comparing the present device with a widely used fasciotome was under way at the time of writing of this study.
胫骨前肌间隔慢性运动性骨筋膜室综合征(ant-CECS)的手术治疗通常使用筋膜刀。在此过程中可能会发生诸如血肿和神经损伤等附带组织损伤。本报告评估了一种用于ant-CECS手术治疗的替代工具的可行性和安全性。
该系统有一个类似窥器的空心管,通过一个2厘米的皮肤切口插入,可使筋膜刀在保护下推进。该装置在双侧ant-CECS患者中进行了测试。术前和术后使用5级语言评定量表(VRS)对症状进行前瞻性评分。分析了14例患者(年龄26±10岁)。在21(范围 = 16 - 25)个月后,通过体格检查和问卷调查确定并发症和手术疗效。
手术技术成功率为100%(28条腿中的28条)。每条腿的手术时间为10±2分钟(范围 = 6 - 14)。未观察到围手术期并发症。1例表浅伤口感染采用非手术治疗。术后21个月时,疼痛(5分制VRS上降低2.2±1.1,P <.001)、紧绷感(降低1.9±1.6,P =.01)、痉挛(降低1.4±1.6,P =.009)、肌肉无力(降低1.6±1.2,P <.001)和感觉改变(降低1.3±1.4,P =.005)均有显著改善。
这种筋膜刀使用简单,可在腿部ant-CECS患者中安全地进行筋膜切开术。在撰写本研究时,一项比较本装置与广泛使用的筋膜刀的随机对照试验正在进行中。